MNPR – monopar therapeutics inc. (US:NASDAQ)
Stock Stats
News
Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? [Yahoo! Finance]
Monopar Therapeutics (NASDAQ:MNPR) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to an "outperform" rating.
Monopar Therapeutics GAAP EPS of -$0.48 misses by $0.05 [Seeking Alpha]
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments [Yahoo! Finance]
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SCHEDULE 13G/A Monopar Therapeutics Filed by: JANUS HENDERSON GROUP PLC
Form 8-K Monopar Therapeutics For: Nov 13
Form 10-Q Monopar Therapeutics For: Sep 30
Form 4 Monopar Therapeutics For: Sep 30 Filed by: Cittadine Andrew
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.